1.1 Nomination. Subject to the above conditions, Given names Suzuken in Japan suzuken as an exclusive deser of the product to customers in the territory, in accordance with the exceptions and restrictions mentioned in it, and Suzuken agrees to this date. For the purpose of fulfilling its obligations as an exclusive distributor, Given Japan grants Suzuken the non-negotiable right (except under Section 15) to market, market and sell the product directly to customers in the country. “Customer” refers to customers who purchase the product for their own internal use and not for other marketing, sales, sale or resale opportunities. Executing a quality distribution agreement requires careful care and attention to the needs of your business. A contract that clearly explains the expectations, responsibilities and duties of both parties is essential to start your relationship on the right foot. There are many factors to consider, including: pharmaceutical manufacturers not only sell products themselves, but also use external partners to bring their products to market and patients. In order to normalize these relationships, a manufacturer and its distribution partners should establish standard contractual structures. CONOR designates BIOTRONIK as a distributor under this agreement regarding products for sale to all buyers for use (or resale in the case of BIOTRONIK negotiators) in the territory, if BIOTRONIK receives an order from a potential buyer for use or resale outside the territory, BIOTRONIK immediately returns this order to CONOR and does not accept these orders. WHEREAS, CONOR is a manufacturer of a variety of medical devices for vascular procedures.

17.2 Publication, press releases. Both parties may issue press releases referring to the existence of an agreement between the contracting parties without disclosing the commercial details of the agreement and, subject to their confidentiality obligations, with respect to the other. The two contracting parties provide the other party with a copy of a draft press release concerning the other contracting party for pre-publication approval. Authorizations are not unduly withheld and issued in a timely manner. CONSIDERANT that BIOTRONIK wishes to sell the products and to be designated as an exclusive distributor in the Annex B area. This agreement is reached from May 25, 2004 (deadline) d) to assist Suzuken in its promotion efforts by sending representatives to attend medical meetings and conferences. as requested by Suzuken, provide explanations and answer questions about the product and its use and attend conferences and fairs, etc., all, when coordinated in advance, subject to reimbursement of Suzuken`s staff availability of reasonable hotel and travel expenses for Given Imaging or Given Japan staff, as appropriate, who travel to Japan to respond to Suzuken`s request in accordance with this Section 4 (d); “Any document submitted to the authorities or submitted to the authorities in order to obtain, modify or maintain marketing authorizations/unlisted positions/other product marketing rights,” in particular, but not limited to analytical, pharmacological, toxicological, medical and clinical documents, as well as analysis of scientific literature and product characteristics, labeling/formulation of containers, external packaging of notices, information leaflets and expert information.